Report cover image

Compounding Chemotherapy Market

Publisher Evolve Business Intelligence
Published Apr 14, 2025
SKU # EVBI19932377

Description

The global Compounding Chemotherapy market is projected to reach $696.34 million by 2028, expanding at a compound annual growth rate (CAGR) of 6.66% from 2021 to 2028. This growth is driven by various macro and microeconomic factors, including the increasing scarcity of opioids.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA]))
By Technology (With Robotic Arms, Without Robotic Arms)
By Dose (Chemotherapeutic, Non-Chemotherapeutics)
By Delivery Method (Gravimetric Automated Compounding Device (weight-based), Volumetric Automated Compounding Device (volume-based))

Key players

Braun Melsungen AG
Pfizer Inc.
Baxter
Grifols SA
The Metrix Company
Added Pharma
Equashield, Millers Pharmacy
Comecer S.P.A.
Omnicell
Loccioni

Table of Contents

Chapter 1. Executive Summary
Chapter 2. Scope of The Study
2.1. Market Definition
2.2. Scope of The Study
2.2.1. Objectives of Report
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends
4.1. Supply/ Value Chain Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitutes
4.2.5. Industry Rivalry
4.3. Impact of COVID-19 on Compounding Chemotherapy Market
4.3.1. Impact on Market Size
4.3.2. Delivery Methodr Trend, Preferences and Budget Impact
4.3.3. Regulatory Framework/Government Policies
4.3.4. Key Players Strategy to Tackle Negative Impact
4.3.5. Opportunity Window
Chapter 5. Market Dynamics
5.1. Introduction
5.2. DRO Analysis
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunities
Chapter 6. Global Compounding Chemotherapy Market, By Compounding Type
6.1. Introduction
6.2. Pharmaceutical Ingredient Alteration (PIA)
6.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
6.4. Pharmaceutical Dosage Alteration (PDA])
Chapter 7. Global Compounding Chemotherapy Market, By Technology
7.1. Introduction
7.2. With Robotic Arms
7.3. Without Robotic Arms
Chapter 8. Global Compounding Chemotherapy Market, By Dose
8.1. Introduction
8.2. Chemotherapeutic
8.3. Non-Chemotherapeutics
Chapter 9. Global Compounding Chemotherapy Market, By Delivery Method
9.1. Introduction
9.2. Gravimetric Automated Compounding Device (weight-based)
9.3. Volumetric Automated Compounding Device (volume-based)
Chapter 10. Global Compounding Chemotherapy Market, By Region
10.1. Introduction
10.2. North America
10.2.1. Introduction
10.2.2. Driving Factors, Opportunity Analyzed and Key Trends
10.2.3. Market Size and Forecast, By Country, 2020 - 2028
10.2.4. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.2.5. Market Size and Forecast, By Technology, 2020 - 2028
10.2.6. Market Size and Forecast, By Dose, 2020 – 2028
10.2.7. Market Size and Forecast, By Delivery Methodr, 2020 – 2028
10.2.8. US
10.2.8.1. Introduction
10.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends
10.2.8.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.2.8.4. Market Size and Forecast, By Technology, 2020 - 2028
10.2.8.5. Market Size and Forecast, By Dose, 2020 – 2028
10.2.8.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.2.9. Canada
10.2.9.1. Introduction
10.2.9.2. Driving Factors, Opportunity Analyzed and Key Trends
10.2.9.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.2.9.4. Market Size and Forecast, By Technology, 2020 - 2028
10.2.9.5. Market Size and Forecast, By Dose, 2020 – 2028
10.2.9.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.3. Europe
10.3.1. Introduction
10.3.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.3. Market Size and Forecast, By Country, 2020 - 2028
10.3.4. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.3.5. Market Size and Forecast, By Technology, 2020 - 2028
10.3.6. Market Size and Forecast, By Dose, 2020 – 2028
10.3.7. Market Size and Forecast, By Delivery Methodr, 2020 – 2028
10.3.8. Germany
10.3.8.1. Introduction
10.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.8.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.3.8.4. Market Size and Forecast, By Technology, 2020 - 2028
10.3.8.5. Market Size and Forecast, By Dose, 2020 – 2028
10.3.8.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.3.9. France
10.3.9.1. Introduction
10.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.9.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.3.9.4. Market Size and Forecast, By Technology, 2020 - 2028
10.3.9.5. Market Size and Forecast, By Dose, 2020 – 2028
10.3.9.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.3.10. UK
10.3.10.1. Introduction
10.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.10.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.3.10.4. Market Size and Forecast, By Technology, 2020 - 2028
10.3.10.5. Market Size and Forecast, By Dose, 2020 – 2028
10.3.10.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.3.11. Italy
10.3.11.1. Introduction
10.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.11.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.3.11.4. Market Size and Forecast, By Technology, 2020 - 2028
10.3.11.5. Market Size and Forecast, By Dose, 2020 – 2028
10.3.11.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.3.12. Rest of Europe
10.3.12.1. Introduction
10.3.12.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.12.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.3.12.4. Market Size and Forecast, By Technology, 2020 - 2028
10.3.12.5. Market Size and Forecast, By Dose, 2020 – 2028
10.3.12.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.4. Asia-Pacific
10.4.1. Introduction
10.4.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.3. Market Size and Forecast, By Country, 2020 - 2028
10.4.4. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.4.5. Market Size and Forecast, By Technology, 2020 - 2028
10.4.6. Market Size and Forecast, By Dose, 2020 – 2028
10.4.7. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.4.8. China
10.4.8.1. Introduction
10.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.8.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.4.8.4. Market Size and Forecast, By Technology, 2020 - 2028
10.4.8.5. Market Size and Forecast, By Dose, 2020 – 2028
10.4.8.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.4.9. India
10.4.9.1. Introduction
10.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.9.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.4.9.4. Market Size and Forecast, By Technology, 2020 - 2028
10.4.9.5. Market Size and Forecast, By Dose, 2020 – 2028
10.4.9.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.4.10. Japan
10.4.10.1. Introduction
10.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.10.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.4.10.4. Market Size and Forecast, By Technology, 2020 - 2028
10.4.10.5. Market Size and Forecast, By Dose, 2020 – 2028
10.4.10.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.4.11. South Korea
10.4.11.1. Introduction
10.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.11.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.4.11.4. Market Size and Forecast, By Technology, 2020 - 2028
10.4.11.5. Market Size and Forecast, By Dose, 2020 – 2028
10.4.11.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.4.12. Rest of Asia-Pacific
10.4.12.1. Introduction
10.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.12.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.4.12.4. Market Size and Forecast, By Technology, 2020 - 2028
10.4.12.5. Market Size and Forecast, By Dose, 2020 – 2028
10.4.12.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.5. Rest of The World (RoW)
10.5.1. Introduction
10.5.2. Driving Factors, Opportunity Analyzed and Key Trends
10.5.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.5.4. Market Size and Forecast, By Technology, 2020 - 2028
10.5.5. Market Size and Forecast, By Dose, 2020 – 2028
10.5.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.5.7. Market Size and Forecast, By Region, 2020 - 2028
10.5.8. South America
10.5.8.1. Introduction
10.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends
10.5.8.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.5.8.4. Market Size and Forecast, By Technology, 2020 - 2028
10.5.8.5. Market Size and Forecast, By Dose, 2020 – 2028
10.5.8.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
10.5.9. Middle East & Africa
10.5.9.1. Introduction
10.5.9.2. Driving Factors, Opportunity Analyzed and Key Trends
10.5.9.3. Market Size and Forecast, By Compounding Type, 2020 - 2028
10.5.9.4. Market Size and Forecast, By Technology, 2020 - 2028
10.5.9.5. Market Size and Forecast, By Dose, 2020 – 2028
10.5.9.6. Market Size and Forecast, By Delivery Methodr, 2020 - 2028
Chapter 11. Competitive Landscape
11.1. Introduction
11.2. Vendor Share Analysis, 2020/Key Players Positioning, 2020
Chapter 12. Company Profiles
12.1. Braun Melsungen AG
12.1.1. Business Overview
12.1.2. Financial Analysis
12.1.3. Product Portfolio
12.1.4. Recent Development and Strategies Adopted
12.1.5. SWOT Analysis
12.2. Pfizer Inc.
12.2.1. Business Overview
12.2.2. Financial Analysis
12.2.3. Product Portfolio
12.2.4. Recent Development and Strategies Adopted
12.2.5. SWOT Analysis
12.3. Baxter
12.3.1. Business Overview
12.3.2. Financial Analysis
12.3.3. Product Portfolio
12.3.4. Recent Development and Strategies Adopted
12.3.5. SWOT Analysis
12.4. Grifols SA
12.4.1. Business Overview
12.4.2. Financial Analysis
12.4.3. Product Portfolio
12.4.4. Recent Development and Strategies Adopted
12.4.5. SWOT Analysis
12.5. The Metrix Company
12.5.1. Business Overview
12.5.2. Financial Analysis
12.5.3. Product Portfolio
12.5.4. Recent Development and Strategies Adopted
12.5.5. SWOT Analysis
12.6. Added Pharma
12.6.1. Business Overview
12.6.2. Financial Analysis
12.6.3. Product Portfolio
12.6.4. Recent Development and Strategies Adopted
12.6.5. SWOT Analysis
12.7. Equashield, Millers Pharmacy
12.7.1. Business Overview
12.7.2. Financial Analysis
12.7.3. Product Portfolio
12.7.4. Recent Development and Strategies Adopted
12.7.5. SWOT Analysis
12.8. Comecer S.P.A.
12.8.1. Business Overview
12.8.2. Financial Analysis
12.8.3. Product Portfolio
12.8.4. Recent Development and Strategies Adopted
12.8.5. SWOT Analysis
12.9. Omnicell
12.9.1. Business Overview
12.9.2. Financial Analysis
12.9.3. Product Portfolio
12.9.4. Recent Development and Strategies Adopted
12.9.5. SWOT Analysis
12.10. Loccioni
12.10.1. Business Overview
12.10.2. Financial Analysis
12.10.3. Product Portfolio
12.10.4. Recent Development and Strategies Adopted
12.10.5. SWOT Analysis
Chapter 13. Key Takeaways

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us